Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sold $33M of NATR
owner at NATURES SUNSHINE PRODUCTS INC. 2,854,607 shares at an average of $11.46, traded Jun 27, 2025, filed Jun 27, 2025.
Score components
- +12Role10% owner
- +25Trade size$32.7M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-023976, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 27, 2025 | SOpen-market sale Common Stockindirect: by Fosun Pharma USA Inc. | -2,854,607 | $11.46 | $33M | 0 | Jun 27, 2025 |
Related signals
Other insiders at NATURES SUNSHINE PRODUCTS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | NATURES SUNSHINE PRODUCTS INC | Bryant J Yates EVP & President, Europe | $162k 9,672 shares | -9% | |
| 46Moderate | NATURES SUNSHINE PRODUCTS INC | Nathan G Brower EVP, General Counsel | $165k 9,996 shares | -17% | |
| 39Weak | NATURES SUNSHINE PRODUCTS INC | Jonathan David Lanoy SVP, Chief Accounting Officer | $83k 5,000 shares | -9% | |
| 17Weak | NATRsell NATURES SUNSHINE PRODUCTS INC | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owner | $30k 2,300 shares | -3% | |
| 28Weak | NATRsell NATURES SUNSHINE PRODUCTS INC | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owner | $145k 10,895 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.